Elevated Capital Advisors LLC Has $545,000 Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Elevated Capital Advisors LLC lifted its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 8.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 58,395 shares of the pharmacy operator’s stock after buying an additional 4,790 shares during the period. Elevated Capital Advisors LLC’s holdings in Walgreens Boots Alliance were worth $545,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Sequoia Financial Advisors LLC boosted its position in Walgreens Boots Alliance by 4.4% during the third quarter. Sequoia Financial Advisors LLC now owns 25,215 shares of the pharmacy operator’s stock valued at $226,000 after purchasing an additional 1,063 shares during the last quarter. Lincluden Management Ltd. raised its stake in shares of Walgreens Boots Alliance by 0.4% during the 3rd quarter. Lincluden Management Ltd. now owns 264,644 shares of the pharmacy operator’s stock worth $2,371,000 after purchasing an additional 1,074 shares in the last quarter. CWA Asset Management Group LLC boosted its holdings in shares of Walgreens Boots Alliance by 9.2% in the 4th quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock valued at $120,000 after buying an additional 1,084 shares during the last quarter. OLD Second National Bank of Aurora grew its stake in shares of Walgreens Boots Alliance by 35.1% in the third quarter. OLD Second National Bank of Aurora now owns 4,562 shares of the pharmacy operator’s stock valued at $41,000 after buying an additional 1,185 shares in the last quarter. Finally, PFG Investments LLC increased its holdings in Walgreens Boots Alliance by 3.8% during the third quarter. PFG Investments LLC now owns 33,916 shares of the pharmacy operator’s stock worth $304,000 after buying an additional 1,245 shares during the last quarter. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

NASDAQ:WBA opened at $11.90 on Tuesday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. The firm has a market cap of $10.28 billion, a price-to-earnings ratio of -1.19, a P/E/G ratio of 1.36 and a beta of 0.64. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $23.76. The firm’s 50-day simple moving average is $9.31 and its 200 day simple moving average is $9.81.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. The company had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The firm’s quarterly revenue was up 7.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.66 earnings per share. As a group, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Stockholders of record on Monday, November 18th were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 8.40%. The ex-dividend date was Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently -9.77%.

Analysts Set New Price Targets

A number of analysts have commented on the stock. UBS Group increased their price target on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research note on Thursday, October 17th. Jefferies Financial Group cut their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Truist Financial lowered their price target on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research report on Monday, October 7th. Evercore ISI raised their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday. Finally, Barclays boosted their target price on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, October 16th. Four analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $12.81.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.